These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 27621567)

  • 1. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
    Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
    World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Wu Y; Li Y; Zheng Q; Li L
    Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
    Oka A; Sartor RB
    Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.
    He Y; Xu R; Wang W; Zhang J; Hu X
    Medicine (Baltimore); 2020 Aug; 99(32):e21502. PubMed ID: 32769886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children.
    Guandalini S; Cernat E; Moscoso D
    Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
    Eindor-Abarbanel A; Healey GR; Jacobson K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
    Dang X; Xu M; Liu D; Zhou D; Yang W
    PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.
    Patel R; DuPont HL
    Clin Infect Dis; 2015 May; 60 Suppl 2(Suppl 2):S108-21. PubMed ID: 25922396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.
    LeBlanc JF; Segal JP; de Campos Braz LM; Hart AL
    Nutrients; 2021 May; 13(6):. PubMed ID: 34071065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebiotics, probiotics and digestive health.
    Balakrishnan M; Floch MH
    Curr Opin Clin Nutr Metab Care; 2012 Nov; 15(6):580-5. PubMed ID: 23037903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
    Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y
    Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
    Roy S; Dhaneshwar S
    World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2020 Feb; 20(1):e13-e24. PubMed ID: 32190365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.